Eledon Pharmaceuticals (ELDN) Net Cash Flow Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.29% |
| Dec 31, 2025 | 135.96% |
| Sep 30, 2025 | -15.12% |
| Jun 30, 2025 | 1.83% |
| Mar 31, 2025 | -43.22% |
| Dec 31, 2024 | 54.56% |
| Sep 30, 2024 | -46.19% |
| Jun 30, 2024 | 34.41% |
| Mar 31, 2024 | 17.78% |
| Dec 31, 2023 | 17.94% |
| Sep 30, 2023 | -67.06% |
| Jun 30, 2023 | -19.78% |
| Mar 31, 2023 | -31.29% |
| Dec 31, 2022 | -38.49% |
| Sep 30, 2022 | -5.99% |
| Jun 30, 2022 | -18.66% |
| Mar 31, 2022 | -32.75% |
| Dec 31, 2021 | -48.64% |
| Sep 30, 2021 | -47.67% |
| Jun 30, 2021 | -24.42% |
| Mar 31, 2021 | 10.39% |
| Dec 31, 2020 | 50.60% |
| Sep 30, 2020 | 41.40% |
| Jun 30, 2020 | 38.76% |
| Mar 31, 2020 | 17.81% |
| Dec 31, 2019 | -57.61% |
| Sep 30, 2019 | -15.26% |
| Jun 30, 2019 | 22.80% |
| Mar 31, 2019 | 3.74% |
| Dec 31, 2018 | -19.02% |